E. Ohman J:or Asset Management 13F: Cuts VEEV Stake by $12M

E. Ohman J:or Asset Management trimmed its investment in Veeva Systems Inc. (NYSE:VEEV), lowering its stake by 26.2% according to a Form 13F filing on October 22, 2026. The firm sold 40,400 shares during the period, finishing the quarter with 113,455 shares of the cloud software provider. That remaining position carried an estimated value of $32.4 million at the time of the report.

VEEV Veeva Systems Inc.

$322.08 ▲ +46.74% year to date

1M 3M YTD

Daily close · Oct 22, 2026

What Changed in E. Ohman J:or Asset Management's Veeva Systems Inc. Position

The asset manager held 153,855 shares of Veeva Systems before the reduction. Shedding 40,400 shares brought the total down to 113,455 shares. The remaining stake represents a substantial holding in the life sciences cloud solutions provider, though the firm opted to pull back its exposure after the stock's recent gains.

Other Institutional Activity in Veeva Systems Inc.

Other large institutional investors adjusted their holdings in Veeva Systems during the same reporting window. Principal Financial Group grew its holdings by 837,806 shares, ending with 4,979,210 shares worth about $1.6 billion. Alliancebernstein L.P. reduced its position by 1,357,670 shares to hold 4,913,322 shares valued at approximately $1.58 billion. Linonia Partnership LP cut its stake by 515,126 shares, finishing with 4,409,598 shares worth about $1.42 billion. AQR Capital Management, LLC expanded its footprint by adding 901,599 shares for a total of 3,498,371 shares valued at roughly $1.13 billion.

Veeva Systems Inc. Stock Down 0.2%

Veeva Systems recently traded around $318.06 as of October 22, 2026, down slightly by 1.1% from its close of $321.63 on the filing date. The stock changes hands near its 52-week high of $322.99 and sits well above its 50-day moving average of $273.90. The company carries a market capitalization of roughly $51.9 billion.

Recent Earnings

Veeva Systems reported trailing twelve-month revenue of $3.46 billion alongside earnings of $6.10 per share. The company operates with a net profit margin of 29.3% and a return on equity of 14.4%. The next quarterly financial update is scheduled for November 25, 2026.

Insider Buying and Selling at Veeva Systems Inc.

Company insiders executed several transactions prior to the filing. President Thomas D. Schwenger sold 10,000 shares on August 27, 2026, at an average price of $281.33 for a total of about $2.8 million, and later sold 1,000 shares on September 14, 2026, at an average price of $265.20. Director Priscilla C. Hung sold 750 shares on September 9, 2026, at an average price of $261.04. Officer Daniel J. Rizzo also disposed of 4,841 shares valued at roughly $1.3 million on October 2, 2026.

Analysts Set New Price Targets

Wall Street analysts have updated their outlooks on the stock in recent months. On August 27, 2026, Mizuho maintained an Outperform rating while raising its price target to $280.00 from $270.00. BMO Capital maintained a Market Perform rating and boosted its target to $270.00 on the same day. Baird kept an Outperform rating and lifted its target to $300.00. Citigroup maintained a Neutral rating with a $273.00 target on August 28, 2026. Later, on October 19, 2026, Barclays maintained an Overweight rating while increasing its price target to $360.00. Analysts hold a consensus buy rating on the stock with a mean price target of $298.70.

About Veeva Systems Inc.

Veeva Systems Inc. develops specialized cloud-based software solutions tailored for the global life sciences sector. Its platforms help pharmaceutical and biotech organizations manage clinical trials, regulatory compliance, and commercial data operations across North America, Europe, and Asia. Institutional adjustments in the stock often reflect broader portfolio rebalancing as the company scales its enterprise offerings.

Bottom Line

Investors tracking Veeva Systems will look to the upcoming earnings report on November 25, 2026, for further updates on software adoption and margin trends. Institutional shifts and insider transaction patterns will remain key focal points for market participants watching the health information services sector.